Trials / Completed
CompletedNCT05613712
Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 229 (actual)
- Sponsor
- University Hospital, Grenoble · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes
Detailed description
In the rheumatology department of the CHU Grenoble Alpes, Professor Baillet and other rheumatologists have set up a holistic assessment of inflammatory rheumatism (rheumatoid arthritis, spondyloarthritis and psoriatic arthritis) and associated co-morbidities in a day hospital. Based on this assessment, a hospital report is drawn up summarising the patient's treatment options, which is then sent to the patient's referring physician. They analysed the first 100 patients in the cohort and showed that 98% of patients were not up to date with their care. Their longitudinal analysis shows that patients update two thirds of the recommendations made within 12 to 18 months. Therefore, the investigators would like to assess the applicability of this screening in these patients, through a questionnaire sent to the 400 patients of the cohort and to their treating physicians.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Patients | Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up |
| OTHER | Referring physician | Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes |
Timeline
- Start date
- 2023-02-11
- Primary completion
- 2023-05-04
- Completion
- 2023-05-04
- First posted
- 2022-11-14
- Last updated
- 2025-12-29
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05613712. Inclusion in this directory is not an endorsement.